GI
MGNX icon

GAMMA Investing’s MacroGenics MGNX Stock Holding History

GAMMA Investing’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-190
Closed -$625 – 3810
2024
Q3 		$625 Sell
190
-1,039
-85% -$4.05K ﹤0.01% 3358
2024
Q2 		$5.22K Sell
1,229
-444
-27% -$4.32K ﹤0.01% 2559
2024
Q1 		$24.6K Buy
1,673
+64
+4% +$967 0.01% 1496
2023
Q4 		$23K Buy
+1,609
New +$11.1K 0.01% 1399

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

GAMMA Investing's MGNX Position: Q4 2024 in Review

GAMMA Investing sold out of MacroGenics (MGNX) in Q4 2024, closing a stake of 190 shares — an estimated $625 sold.

GAMMA Investing first reported a position in MGNX in Q4 2023 and held it in 4 quarters. The position peaked at $24.6K in Q1 2024. 128 funds tracked by Wall St. Rank hold MGNX as of Q4 2024.

  • GAMMA Investing reported no remaining MacroGenics position as of Q4 2024 after selling out during the quarter.
  • GAMMA Investing sold 190 MacroGenics shares in Q4 2024, an estimated $625.
  • GAMMA Investing first reported a position in MacroGenics in Q4 2023 and held it in 4 quarters.
  • GAMMA Investing's MacroGenics position peaked at $24.6K in Q1 2024.
  • 128 funds tracked by Wall St. Rank held MacroGenics as of Q4 2024.

Based on GAMMA Investing's 13F filing for Q4 2024, filed 3 Jan 2025.